Refractory Thyroid Gland Papillary Carcinoma
3 clinical trials · Condition
◉ Watch Refractory Thyroid Gland Papillary Carcinoma
| Record | Firm | Date |
|---|---|---|
| Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer (NCT05410821) | The First Affiliated Hospital of Xiamen University | 2022-06-15 |
| Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer (NCT01208051) | National Cancer Institute (NCI) | 2010-09-09 |
Track Refractory Thyroid Gland Papillary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.